Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes.
Oral and intravenous 1'-cyano-substituted adenosine-like antivirals for early COVID-19.
Vagus Nerve Dysfunction in the Post-COVID-19 Condition: a pilot cross sectional study.
"The burden of post-acute COVID-19 symptoms in a multinational network cohort analysis".
Determinants of the onset and prognosis of the post-COVID-19 condition: a 2-year prospective observational cohort study.
Genetic risk, adherence to healthy lifestyle and acute cardiovascular and thromboembolic complications following SARS-COV-2 infection.
Effectiveness and safety of integrase strand transfer inhibitors in Spain: a prospective real-world study.
HIV drug resistance in the era of contemporary antiretroviral therapy: A clinical perspective.
Consistent Effects of Early Remdesivir on Symptoms and Disease Progression Across At-Risk Outpatient Subgroups: Treatment Effect Heterogeneity in PINETREE Study.
Impact of obefazimod on viral persistence, inflammation, and immune activation in people with HIV on suppressive antiretroviral therapy.